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Lay summary: A Choledochal malformation is an very rare dilatation of the bile duct. To prevent 
the development of bile duct cancer an operation is advised. We gathered the data of 123 A
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patients operated upon and describe their diagnosis, surgery and outcome through a nationwide 
collaborative study.
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Abstract
Background and Aims
Patients with a choledochal malformation, formerly described as cysts,  are at increased risk of 
developing a cholangiocarcinoma and resection is recommended. Given the low incidence of CM 
in western countries, the incidence in these countries is unclear. Our aim was to assess the 
incidence of malignancy in CM patients and to assess postoperative outcome.
Methods
In a nationwide, retrospective study, all adult patients, who underwent surgery for CM between 
1990 and 2016 were included. Patients were identified through the Dutch Pathology Registry and 
local patient records and were analysed to determine the incidence of malignancy, as well as 
postoperative mortality and morbidity.
Results
A total of 123 patients with a CM were included in the study (Todani Type I, n=71; Type II, n=10; 
Type III, n=3; Type IV, n=27; unknown, n=12). Median age was 40 years (range 18-70) and 81% 
were female. The majority of patients (99/123) underwent extrahepatic bile duct resection, with 
additional liver parenchyma resections in eight patients, only exploration in two, and a local cyst 
resection in eight patients. Postoperative 30-day mortality was 2% (2/123) and limited to 
patients who underwent liver resection. Severe morbidity occurred in 24%. In 14 of the 123 
patients (11%) a malignancy was found in the resected specimen. One patient developed a 
periampullary malignancy 7 years later.
Conclusions
In a large Western series of CM patients 11% were found to have a malignancy. This justifies 
resection in these patients, despite the risk of morbidity (24%) and mortality (2%).
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INTRODUCTION
Choledochal malformation (CM) is a rare congenital malformation of the bile ducts and it is 
considered a premalignant condition. CM is generally characterized by fusiforme or saccular 
dilatation of the extrahepatic (or larger intrahepatic) bile duct(s) and an alternative (now 
obsolete) term for these abnormalities is choledochal cysts. The exact incidence of CM is largely 
unknown and is race-dependent. Some authors report an estimated 100 to a 1000 higher 
incidence of CM in Asia, compared to Western countries, with a strong female preponderance.(1-
4) In children the incidence of CM is estimated at 1 in 59.000 live births.(5, 6) This is higher than 
previously suggested in literature, possibly as a result of improved detection of CM with the 
introduction of antenatal ultrasound.(7) The maximum diameter of the normal common bile duct 
has been described in the Japanese population by the JSGPM in 2016, but no norm value exists 
for non-Asian populations.(8)
Because of potential malignant degeneration, standard treatment of CM consists of prophylactic 
resection of the affected part of the extrahepatic bile duct, including the gallbladder, followed by 
restoration of the biliodigestive tract via a Roux-Y hepaticojejunostomy (HJ). With this procedure 
the premalignant tissue is resected to avoid the later formation of cholangiocarcinoma (CCA) or 
gallbladder carcinoma (GBC). It is, however, difficult to ascertain the real risk of formation of 
biliary malignancies because the prevalence of asymptomatic CM in the general population is 
unknown.
In the Western population, the incidence of CM in adults is understudied with only three studies 
describing cohorts larger than 36 patients and this lack of data forms the basis for our 
investigation.(9-11) Extrahepatic bile duct resection (EHBDR) is associated with considerable 
short-term morbidity and mortality. Long-term complications include anastomotic strictures of 
the HJ often requiring radiological and/or surgical re-intervention. Nevertheless, detailed 
information on the occurrence and optimal treatment of these complications is lacking. Because 
of the impact of these complications, weighing of the risks and benefits of prophylactic resection 
poses a clinical problem for patients and surgeons. 
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The aim of this study was to analyse a nationwide cohort of adult patients with CM, with special 
interest for the occurrence of biliary malignancy associated with CM. Furthermore, we assessed 
the short-term and long-term complications of surgical therapy.   
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Methods and Materials
This was a multicentre retrospective cohort study. Each of the eight academic medical centres in 
The Netherlands participated in the patient search. In the Netherlands, major biliary surgery, as 
well as surgery for congenital malformations, is performed mainly in one of these centres. The 
study was approved by the medical ethics committee of the University Medical Center Groningen 
(UMCG) and the need for patients’ informed consent was waived (reference number 
METC2016/341). STROBE guideline for reporting cohort studies were adhered to. (12)
Patient population and identification
A structured search of the Dutch Pathology Registry (PALGA) was performed using a selection of 
medical subject headings (MeSH) criteria as listed in Appendix 1. PALGA, established in 1971, is 
the nationwide network and registry of histo- and cytopathology.(13) It prospectively collects 
data from all Dutch pathology laboratories and serves as a central basis for research. Conclusions 
of pathology excerpts of all potential cases were read and, when appropriate, excerpts were 
studied in more detail. If relevant to the present study, the selected pathology data were 
returned to each participating centre and matched with the hospital record for further analysis.
Using the same MeSH criteria, hospital-based registries were searched for eligible patient files. 
Data retrieved from PALGA and from hospital-based registries were cross-checked to avoid 
duplicates and this patient identification was used for on-site medical file evaluation
To determine the incidence of CM, we aimed to include all consecutive adult (Age ≥ 18 years at 
the time of surgery) patients who had underwent a surgical resection for CM, with or without 
CCA, between 1990 and 2016. We excluded patients who were not operated upon and patients 
in whom the final diagnosis was not a CM as termed in the operation report or the postoperative 
discharge letter. In case of an unclear diagnosis or clear secondary, acquired, dilatation of the 
bile ducts not related to CM, patients were also excluded. We did collect data on patients with a A
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Type V CM but we excluded these patients from the present analysis because their disease is 
located deep into the liver parenchyma and its surgical treatment is strikingly different.
Data collection and outcome definitions
We extracted the data from patient charts and anonymously recorded the data using a 
standardised case record form (CRF, Appendix 2). This CRF was defined and maintained during 
the complete data acquisition. All data were collected by at least 2 researchers (either RdK, AMS 
and/or AtH) and disagreements between researchers were resolved by consensus. The 
parameters collected included patient demographics (sex, age at time of surgery and the length 
of time patients were followed-up), presenting symptoms, type of CM according to the clinically 
determined Todani classification as displayed in figure 1,(14) The operative details, postoperative 
complications and the incidence of CCA or gallbladder adenocarcinoma (GBA) at the time of 
surgery or during follow-up were registered. 
We graded the short-term complications (≤30 days) according to the highest Clavien-Dindo 
classification.(15) We considered short-term complications grade 3 or higher as major 
complications and specified them in more detail. These included hepaticojejunostomy leakage, 
intra-abdominal abscess or collection, haemorrhage (requiring an intervention) and sepsis. 
Postoperative mortality was defined as death by any cause within 30 days of surgery.
Long-term complications (> 30 days) included recurrent cholangitis, which we defined as jaundice 
with fever (> 38.5 °C) and abdominal pain), anastomotic stricture of the HJ, bile stones (intra-
hepatic stone formation confirmed by ultrasonography), liver abscesses (fever with bacterial 
infection proven via culture and infection of the liver confirmed by ultrasonography), incisional 
hernia requiring re-intervention.
Statistics
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Analytical statistics were used to compare groups within the cohort. Continuous data were 
presented as median with range, and categorical data as numbers with percentages. Missing 
data was excluded from the analysis per item. The SPSS (IBM Corporation, Armonk, NY, USA) 
package 26 was used for the analysis.
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Results
A total of 1329 excerpts of 1013 patients treated between January 1990 and December 2015 
were identified through searching the PALGA database. After reading the excerpts, we 
considered 232 reports on 227 patients of sufficient interest to warrant detailed investigation 
and we subsequently matched these with local hospital records including the year 2016.
After combining the two sources of data, we identified a total of 152 adult patients with CM who 
had undergone surgery. From this number we excluded 29 patients with Type V malformations. 
Ultimately therefore, we analysed the data pertaining to 123 patients. This gave an overall 
incidence of 5.85 treated cases of CM (Type I-V) per year, or 4.73 cases of CM Type I to IV per 
year. In 2000, the size of the adult population was approximately 11.9 million.(15) 
Patient characteristics
In Table 1, we provide a list of the patients’ characteristics and surgical details. Female patients 
formed the majority of patients (81%, 100/123). Median age at surgery was 40 years (range 18-
70). Data on presenting symptoms and associated diagnosis were missing in 13 patients. 
Symptoms were present in 88% of patients (98/110) and consisted mainly of abdominal pain 
(84%, 92/110) with several patients suffering from more than one symptom. Choledocholithiasis 
was present in 25% and pancreatitis in 8%. Jaundice was present in 12 upon diagnosis and 
resolved before surgery with endoscopic drainage in all patients. The combination of an 
abdominal mass, jaundice and pain was present in only one patient. No signs of liver fibrosis or 
splenomegaly were observed. At the moment of evaluation of the records 15 patients had died 
with data missing for five patients. Ultrasound (US) was performed in 56 of 108 patients, 
computed tomography (CT) in 44 of 109, both US and CT in 18. Magnetic resonance imaging was 
performed in 69 patients and at least one imaging study was ascertained in 113, with missing 
data in 10. Abnormal pancreatico-biliary maljunction was present in 22 and absent in 20, with 81 
patients having missing data.
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The most common of types of CM were Todani Type I with 58% (71/123) and type IV 22% 
(27/123). Surgical resection of the malformation was attempted in all 123 patients whereby 
details on the type of surgery were missing for five patients. Three patients were operated on the 
day of diagnosis, median time to surgery was 99 days (47-198 days, 25-75 percentile) Fourteen 
patients had a period of more than one year between the establishment of the diagnosis and 
surgery. Extrahepatic bile duct resection followed by HJ was performed in 80 percent (99/123). 
Two explorations without resection were performed due to extensive malignancy. In seven 
patients, a Type II cyst was resected without the need for formal bile duct resection. EHBDR with 
additional parenchymal resections were performed in eight patients; these included five major 
liver resections, one pancreatic resection and one combination of a right-sided hemihepatectomy 
with a pylorus preserving pancreatico-duodenectomy. One patient had a conversion of a 
cystoduodenostomy to a formal resection of the cyst and reconstruction with HJ with a 
concomitant colon resection. In one instance, in 1994, a hepatico-duodenostomy was performed 
because the patient lacked suitable small intestine. One cyst resection was performed and bile 
continuity was achieved by means of a duct-to-duct anastomosis, in a patient with substantial co-
morbidity. Open surgery was performed on all patients.
Postoperative outcome
We list postoperative outcomes that included short-term and long-term complications in Table 2. 
One half of the patients did not suffer any short-term complications. Clavien-Dindo Grades III and 
IV complications were present in one-fifth of the patients, the majority of which consisted of 
sepsis and bile leakage. Two patients died postoperatively as a result of bile leakage followed by 
sepsis and multi-organ failure. Neither of these patients had a malignancy in their final 
pathology. Relaparotomy was performed in 13 patients and nine patients required radiological or 
endoscopic reinterventions. The median length of stay in hospital was 10 days. There was no 90-
day mortality. No long-term complications occurred in 64% of patients. Serious complications 
were present in 23 percent of patients and half of these patients suffered recurrent cholangitis. 
Seventeen patients with EHBDR had an anastomotic stenosis or stricture during follow up. Just 
over half of these patients required percutaneous transhepatic drainage (eight patients, 7%) or 
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endoscopic treatment (four patients, 3%). Surgical reinterventions after 30 days were necessary 
in 13% of patients (16/121) which included four revisions of the HJ.
Oncological outcome
Patient follow-up was highly variable with a median length of 1.7 years (range 0.1 – 15.7 years). 
Malignancy was proven in 14 patients (11 percent) by final pathology evaluation with a median 
age of 45.6 years (range 24.4-68.1 yrs.). Twelve patients were diagnosed with CCA and 2 patients 
with GBA. Of those, malignancy was suspected prior to surgery in 4, discovered during surgery in 
6 and detected after surgery, in final pathology, in 3 patients (3%, 5% and 2% respectively). One 
patient who during EHBDR with HJ did not have a malignancy developed a peri-ampullary cancer 
7 years after surgery. It is unclear whether this was related to the previous CM. Cancer was only 
found in type I and type IV malformations. Since a more detailed evaluation of the subtypes of 
CM was not recorded this data was not available to us.
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Discussion
CM is a rare diagnosis of which the true incidence in the Western World is unknown. Based on 
the present nationwide cohort of 26 years, the incidence of surgically treated CM in this Western 
adult population of 11.9 million was 5.85 patients per year. It is highly likely that the improved 
detection of congenital defects with ultrasound will bring forward the detection of choledochal 
malformations.(6)With improved detection and imaging mild dilatation of the bile duct, without 
distal obstruction, will spark the discussion if a malformation is present. Guidelines for the Asian 
population by Hamada et al. delineate clear age cohort maximum values for the diameter of the 
common bile duct but it remains to be seen if these data are useful for other populations. It is 
unlikely that these guidelines had an impact on clinical decisions of our cohort since they were 
published at the end of the treatment period.(8)
The incidence of biliary malignancy in the present cohort was 11%. Severe morbidity following 
resection was 22% and mortality was 2%. Leakage of the hepaticojejunostomy was detected in 
14 patients (13%), higher than expected with two of these patients having additional 
parenchymal resections besides the EHBDR. Long-term complications occurred in 26% of 
patients. This rate of complications and operative mortality seems acceptable in the light of the 
high risk of malignancy, especially because the majority of complications occurred in the group of 
patients who underwent additional parenchymal resections as a result of the suspicion or 
presence of cancer. Furthermore, more than half of the malignancies were not recognized 
preoperatively and would have been missed if patients did not undergo prophylactic surgery. 
In a large cohort from the USA, the occurrence of major complications following surgery for CM 
was reported to be as high as 56% with a mortality rate of 7%.(11) Another American study by 
Nicholl et al. in 51 operated patients reported a morbidity rate of 25% with no operative 
mortality.(17) Postoperative morbidity and mortality rates in surgery for cholangiocarcinoma are 
known to be lower in Asian countries compared to western countries in the Western World.(18) 
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Accordingly, reported morbidity and mortality rates following surgery for CM are also lower in 
Asian series, 3-13% and 0-0.2% respectively.(19, 20)
The incidence of biliary malignancy found in this study is in accordance with a recent meta-
analysis reporting a prevalence of malignancy of 10.7%.(1) Previous publications of patient series 
in the Western World reported varying percentages of malignancy, ranging from 3 to 19%.(9-11, 
17, 21) This may be explained by the small sample sizes of some of these studies and by the fact 
that these studies also included patients with Caroli’s disease (Todani Type V CM). In this study 
magnetic resonance imaging did not display cancer in two-thirds of those patients who, in final 
pathology, showed to have an adenocarcinoma. Screening for cancer in patients who opt for 
watchful waiting instead of prophylactic surgery remains challenging and, possibly dangerous.
This patient cohort, as a result of the nationwide collaboration of academic centres, provides 
new insight into CM in the Western World. The completeness of the present cohort was 
ameliorated by identifying patients with CM by means of a systematic search of the pathology 
register, as well as through the local hospital registries including operative reports and discharge 
letters. The combination of pre-operative imaging, operative notes (from a dedicated academic 
HPB surgeon) and discharge letter offers the best available retrospective tool to avoid inclusion 
of other diagnosis then CM. Of course, one can never be 100% certain in a retrospective study. 
We do, however, note limitations to the present study. First, the fact that in the past some non-
academic hospitals sporadically have performed resections for CM possibly leads to 
underestimating of the national incidence.(22) Second, the fact that not all patients with CM will 
become symptomatic and may therefore not be diagnosed  at all,  contributes to an 
underestimation of the true prevalence of CM. Third, despite the extended time span of covered 
by our study and the multicentre collaboration, the rarity of this diagnosis kept the sample size 
small, prohibiting extensive statistical analysis. This also affected reliable detection of 
concomitant malformations like the abnormal pancreatico-biliary maljunction or vascular 
malformations since no re-evaluation of the diagnostic studies was performed.. Lastly, the 
retrospective nature of the study, with data missing on average in 10% of patients, and the 
variety in length of follow-up (on account of a lack of a structured follow-up protocol) may have 
led to information bias. The findings of this study with a substantial amount of postoperative A
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effects have lead us to instate a structured yearly follow up with ultrasound evaluation and 
laboratory evaluation, even in absence of complaints.
On account of the short duration of follow-up it is difficult to draw conclusions from this study on 
the risk of malignant transformation after resection of CM. If we include the one patient in the 
present study with a tumour in the periampullary region, then this risk was 0.8%. This is in line 
with results from several Asian patient cohorts, that reported the incidence of malignant 
transformation after cyst resection to be 0.6-1.1%.(19, 20, 23) Especially for Type IVa CM the risk 
of malignant transformation is of interest, because EHBDR without liver resection, as is usually 
performed, would mean incomplete resection of the bile duct deformity. Future studies with 
longer follow-up and intercontinental collaboration could provide more detailed insight into the 
factors associated with the risk of malignant transformation. Furthermore, the prognosis of 
patients with CM who develop a biliary malignancy should be elucidated further. 
Resection of CM as a prophylactic therapy for CCA remains the pivotal recommendation to all 
newly detected patients with CM in view of the high risk of malignant transformation.
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Figure 1
Todani Classification of choledochal malformations including Magnetic Resonance Cholangio-
Pancreatography of matching category
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TABLES
Table 1. Patient characteristics and operative details
N = 123 %/range
Age (yrs, median, range) 40 18-70
Female patients 100 81
ASA classification (n=79*):
- 1-2 75 95
- ≥3 4 5
Presenting symptoms (n=110¥)
- None 12 11
- Abdominal pain 92 84
- Nausea 45 41A
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- Fever 18 16
- Jaundice 12 11
- Abdominal mass 4 4
Associated diagnosis at presentation 
(n=110¥)
- Cholelithiasis 27 25
- Cholangitis 10 9
- Pancreatitis 9 8
- Malignancy 4 4
- Ruptured cyst 0 0
- Biliary cirrhosis 0 0
- Portal hypertension 0 0
Type (Todani classification) 
- I 71 58
- II 10 8
- III 3 2
- IV 27 22
- Unclear 12 10
Surgery
- Exploration, no resection 2 2
- Local cyst resection (Type II 
malformation)
7 6
- EHBDR+ HJ 99 80
- EHBDR + HJ + parenchymal 
resection:
8 7
- Other 2 2
- Missing 5 4
Operative time in minutes (median, IQR) 248 90-1085
Abbreviations: ASA, American Society of Anesthesiologists; EHBDR, extrahepatic bile duct resection; HJ, 
hepaticojejunostomy.  
* data was missing on 44 patients; ¥ Data was missing on 13 patientsA
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Table 2. Postoperative outcomes
Short-term outcomes
N = 123 %/range
Missing data 12 10
No morbidity 56 50
Mild morbidity (CD 1-2) 28 25
Severe morbidity (CD 3) 20 18
ICU/multi-organ failure (CD 4) 5 5
Postoperative mortality (CD 5) 2 2
Sepsis 16 14
Intra-abdominal abscess 15 14
Hepaticojejunostomy leakage 14 13
Wound infection 9 8
Relaparotomy 9 8
Cholangitis 6 5
Haemorrhage 3 3
Length of hospital stay in days (median, range) 10 4-69
Long-term outcomes
N = 121 %/range
Lost to follow up/ missing data 12 10
No long-term complication 78 72
Any long-term complication 31 28
Anastomotic stricture/stenosis 17 16
Recurrent cholangitis 13 12
Incisional hernia 6 6
Liver abscess 1 1
(Recurrent) cholelithiasis 3 7
Secondary biliary cirrhosis 0 0
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Length of follow-up in years (median, range) 1.7 0.1 – 15.7
Appendix 1
PALGA MESH search criteria (translated into English):
Choledochalcyst
Choledochal*cyst
Ductus choledochus*cyst
Ductus choledochus*inborn error
Extrahepatic bile duct*inborn error
Choledochocele
Caroli’s disease
Choledochalmalformation
Choledochal*malformation
Ductus choledochus*malformation
Cholangiocarcinoma
Bile duct carcinoma
Klatskin tumour
Choledochal*adenocarcinoma
Choledochal duct*adenocarcinoma
Bile duct*adenocarcinoma
Extrahepatic bile duct*adenocarcinoma
Appendix 2: CRF 
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